Shape-based virtual screen for the discovery of novel CDK8 inhibitor chemotypes. (Record no. 29241991)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01529 a2200421 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250518015628.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 202003s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1464-3405 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1016/j.bmcl.2018.12.065 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | He, Lian-Jun |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20200305 |
245 00 - TITLE STATEMENT | |
Title | Shape-based virtual screen for the discovery of novel CDK8 inhibitor chemotypes. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Bioorganic & medicinal chemistry letters |
Date of publication, distribution, etc. | 02 2019 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 549-555 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article; Research Support, Non-U.S. Gov't |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cell Proliferation |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Colorectal Neoplasms |
General subdivision | pathology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cyclin-Dependent Kinase 8 |
General subdivision | antagonists & inhibitors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Discovery |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Screening Assays, Antitumor |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | G1 Phase |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | HCT116 Cells |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Molecular Docking Simulation |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Phosphorylation |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Protein Kinase Inhibitors |
General subdivision | chemistry |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | S Phase |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | STAT1 Transcription Factor |
General subdivision | metabolism |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Zhu, Yi-Bao |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Fan, Qing-Zhu |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Miao, Dong-Dong |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Zhang, Sheng-Peng |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Liu, Xiao-Ping |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Zhang, Chao |
773 0# - HOST ITEM ENTRY | |
Title | Bioorganic & medicinal chemistry letters |
Related parts | vol. 29 |
-- | no. 4 |
-- | p. 549-555 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1016/j.bmcl.2018.12.065">https://doi.org/10.1016/j.bmcl.2018.12.065</a> |
Public note | Available from publisher's website |
No items available.